Potential of phage therapy for the treatment of diabetic foot infections
- 6 January 2026
- journal article
- review article
- Published by Springer Nature in Folia Microbiologica
- Vol. 71 (3) , 497-513
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Innovative Non-antibiotic Strategies for Combating Methicillin-Resistant Staphylococcus aureus in Diabetic Foot InfectionsCurrent Microbiology, 2025
- Isolation, characterization, and potential application of Acinetobacter baumannii phages against extensively drug-resistant strainsVirus Genes, 2024
- Understanding and Treating Diabetic Foot Ulcers: Insights into the Role of Cutaneous Microbiota and Innovative TherapiesSkin Health and Disease, 2024
- Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound modelVirus Genes, 2023
- Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infectionInternational Microbiology, 2022
- Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)Diabetes/Metabolism Research and Reviews, 2020
- Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategiesArchives of Microbiology, 2020
- Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due toStaphylococcus aureusJAMA Otolaryngology–Head & Neck Surgery, 2019
- Oral Antibiotic Treatment Induces Skin Microbiota Dysbiosis and Influences Wound HealingMicrobial Ecology, 2014
- Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis — case reportFolia Microbiologica, 2009